Voice for Science and Solidarity by Geert Vanden Bossche
Geert Vanden BosscheMass infection prevention and mass vaccination with leaky Covid-19 vaccines in the midst of the pandemic can only breed highly infectious variants.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 310 | Subscribers | Read | voiceforscienceandsolidarity.substa... |
Curious about how many subscribers Voice for Science and Solidarity by Geert Vanden Bossche has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #29 | |
| #32 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Predictions on the evolution of the Covid-19 pandemic
The manuscript posted below is one I wrote roughly three and a half years ago! At that time, I outlined how and why glycosylation of the spike (S) protein would be expected to evolve under conditions of partial, i.e., insufficient populatio...
There’s nothing more frustrating than knowing you’re talking common sense but everyone else is just calling you stupid or fear-mongering.
This is just a heads-up regarding my upcoming Substack post. I always say -genuinely-that it will be my last, but much like the pandemic itself, my insights into how my unchanged predictions are likely to unfold continue to develop. While I...
Why Large-Scale O-Glycosylation on SARS-CoV-2 Spike Is Unlikely Until It Becomes Necessary.
More and more people are now turning to AI to present themselves as experts in fields they clearly know nothing about. It’s a trend that’s understandable, of course, but it becomes obvious immediately, especially when you see them throwing ...
Authors
The writers behind this newsletter.
PhD, DVM Independent Vaccine Research Consultant Vaccine Discovery & Preclinical Research.
Frequently Asked Questions
How can I access the email archive for this newsletter?
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does this newsletter have?
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in this newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like this newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to this newsletter?
Scroll up to where it says Similar Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact this newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.